HHealthcare Read More These 4 charts show the scale of Novo Nordisk’s woesFebruary 25, 2026 Novo Nordisk was the first company to make a GLP-1 drug for weight loss and became Europe’s most…
EEconomy Read More Fed expectedly held rates — Powell’s comments drew interestJanuary 29, 2026 Jerome Powell, chairman of the US Federal Reserve, during a news conference following a Federal Open Market Committee…
HHealthcare Read More Roche Shares Rise After Obesity Drug Shows 18% Greater Weight LossJanuary 27, 2026 This article first appeared on GuruFocus. Roche Holding AG (RHHBY) is beginning to show tangible progress in obesity…
MMedication Read More Novo Nordisk faces ‘must-win’ battle over U.S. Wegovy, Ozempic in 2026January 1, 2026 Still life of the big three injectable prescription weight loss medicines. Ozempic, Victoza and Wegovy. (Photo by: Michael…
AArtificial intelligence Read More Markets could face ‘everything bubble’ as selloff rages onNovember 24, 2025 Global stocks have fluctuated wildly over the past week, as concerns about AI valuations hang over equity markets.…